Transfusion Thresholds for Coronary Artery Disease

Introduction to Transfusion Guidelines

The American College of Cardiology recommends transfusing patients with stable coronary artery disease when hemoglobin falls below 8 g/dL or when symptoms of anemia develop, whichever occurs first 1, 2.
The American Association of Blood Banks suggests a restrictive transfusion strategy in hospitalized patients with cardiovascular disease, with consideration of transfusion for patients with symptoms or hemoglobin <8 g/dL (weak recommendation) 4, 5.

The 2014 ACC/AHA perioperative guidelines recommend adherence to a restrictive transfusion strategy in hospitalized patients with cardiovascular disease, with consideration for transfusion when hemoglobin <8 g/dL or symptoms develop 1, 2.
A 2020 meta-analysis of critical care patients with chronic cardiovascular disease found no significant difference in mortality or new-onset acute coronary syndrome between restrictive and liberal strategies, suggesting 7.0 g/dL is sufficient 6, 7.
A 2016 meta-analysis of 3,033 patients with cardiovascular disease found restrictive strategies were associated with a 78% increased risk of acute coronary syndrome (RR 1.78, 95% CI 1.18-2.70) 6.

The European Society of Cardiology recommends withholding transfusion unless hemoglobin decreases below 8 g/dL in patients with acute coronary syndrome 4, 5.
Post-cardiac surgery patients should use a restrictive threshold of 7.5-8.0 g/dL (GRADE 1+, strong agreement) 6, 7.
Three large randomized trials with meta-analyses (>8,800 patients) demonstrated no difference in 30-day or 6-month mortality, myocardial infarction, arrhythmias, stroke, or renal failure between restrictive and liberal strategies in post-cardiac surgery patients 6, 7.

If hemoglobin <8 g/dL, consider transfusion 1, 2, 3.
If hemoglobin ≥8 g/dL but symptoms present, consider transfusion regardless of hemoglobin level 1, 2, 3.
If hemoglobin ≥8 g/dL and no symptoms, defer transfusion 1, 2.

Do not rely solely on hemoglobin concentration without assessing symptoms - CAD patients may develop ischemia at higher hemoglobin levels than other populations 1, 2, 3.
Do not use a 7 g/dL threshold in CAD patients - while safe in general populations, the 8 g/dL threshold is more appropriate for cardiovascular disease 1, 2.
Do not transfuse multiple units without reassessment - single-unit transfusions with reassessment reduce unnecessary exposure 8.

The decision to transfuse must weigh the risks of transfusion (increased nosocomial infections, transfusion-related acute lung injury, transfusion-associated circulatory overload, immunomodulating effects) against the risks of anemia in CAD (reduced oxygen delivery to potentially ischemic myocardium, increased cardiac output demand, potential triggering of acute coronary syndrome) 1, 2, 3, 8.